Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PBYI | PUMA BIOTECHNOLOGY INC | $171.25M | $232.71M | $54.66M | $38.07M | $0.77 | 2.68% | 0.73% | 133.33% | N/A | 2025-07-31 | ||
EXEL | EXELIXIS INC | $12.43B | $2.30B | $894.63M | $643.57M | $2.25 | 24.49% | 18.61% | 251.56% | 18.57% | 2025-08-12 | ||
AUPH | AURINIA PHARMACEUTICALS INC | $1.22B | $247.30M | $65.88M | $39.85M | $0.29 | 29.20% | 278.58% | N/A | N/A | 2025-07-31 | ||
RIGL | RIGEL PHARMACEUTICALS INC | $345.83M | $203.08M | $48.45M | $37.18M | $2.10 | 68.74% | 14.67% | N/A | N/A | |||
ZVRA | ZEVRA THERAPEUTICS INC | $699.35M | $40.59M | -$60.30M | -$91.99M | -$1.92 | 46.47% | 22.15% | N/A | N/A | 2025-08-19 | ||
HALO | HALOZYME THERAPEUTICS INC | $7.10B | $1.08B | $704.60M | $485.36M | $3.85 | 25.65% | 45.83% | 57.14% | N/A | 2025-08-12 | ||
PTCT | PTC THERAPEUTICS INC | $3.92B | $1.77B | $846.90M | $594.84M | $7.56 | 91.12% | 40.69% | N/A | N/A | 2025-07-31 | ||
NAGE | NIAGEN BIOSCIENCE INC | $886.95M | $107.93M | $16.04M | $14.11M | $0.18 | 29.77% | 16.36% | N/A | N/A | |||
CRMD | CORMEDIX INC | $770.49M | $82.55M | $17.67M | $17.18M | $0.26 | N/A | 235.70% | N/A | N/A | 2025-08-07 | ||
CPRX | CATALYST PHARMACEUTICALS INC | $2.64B | $534.65M | $296.55M | $197.35M | $1.65 | 29.97% | 35.05% | 175.00% | 31.48% | 2025-08-06 | ||
BMRN | BIOMARIN PHARMACEUTICAL INC | $11.17B | $2.95B | $777.43M | $523.88M | $2.75 | 19.36% | 10.32% | 152.29% | 33.85% | 2025-08-05 | ||
INCY | INCYTE CORP | $13.55B | $4.41B | $406.83M | $21.27M | $0.29 | 17.13% | 14.63% | -91.29% | N/A | 2025-07-28 | ||
BCRX | BIOCRYST PHARMACEUTICALS INC | $1.87B | $503.49M | $47.59M | -$53.47M | -$0.26 | 41.67% | 60.16% | N/A | N/A | 2025-07-31 | ||
AKBA | AKEBIA THERAPEUTICS INC | $1.04B | $184.91M | $10.87M | -$45.31M | -$0.22 | -1.24% | -12.02% | N/A | N/A | 2025-07-31 | ||
CSBR | CHAMPIONS ONCOLOGY INC | $110.20M | $58.59M | $8.10M | $6.43M | $0.47 | 19.03% | 13.51% | N/A | N/A | 2025-07-17 | ||
HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $1.99B | $744.85M | $237.95M | $152.72M | $2.67 | 20.62% | N/A | 13.62% | N/A | 2025-08-12 | ||
KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $2.10B | $481.17M | -$1.55M | -$16.95M | -$0.24 | 59.45% | N/A | N/A | N/A | 2025-07-29 | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | $41.17B | $2.35B | -$164.54M | -$269.70M | -$2.09 | 17.21% | 52.37% | N/A | N/A | 2025-07-30 | ||
IMCR | IMMUNOCORE HOLDINGS PLC | $1.77B | $333.58M | $1.93M | -$21.63M | -$0.43 | 25.75% | N/A | N/A | N/A | 2025-08-06 | ||
BDTX | BLACK DIAMOND THERAPEUTICS INC | $167.18M | $70.00M | $5.44M | $5.09M | $0.08 | N/A | N/A | N/A | N/A | 2025-08-12 | ||
INVA | INNOVIVA INC | $1.23B | $369.84M | $14.61M | -$59.72M | -$0.95 | 18.70% | 5.39% | N/A | N/A | 2025-07-30 | ||
NVO | NOVO NORDISK A S | $307.82B | $46.00B | $23.12B | $15.87B | $3.57 | 24.47% | 18.77% | 18.06% | 22.09% | 2025-08-06 | ||
PLX | PROTALIX BIOTHERAPEUTICS INC | $113.04M | $59.76M | $7.16M | $3.91M | $0.05 | 0.18% | -1.94% | -50.00% | N/A | 2025-08-18 | ||
FENC | FENNEC PHARMACEUTICALS INC | $242.77M | $30.91M | -$11.14M | -$14.44M | -$0.53 | -31.23% | N/A | N/A | N/A | 2025-08-07 | ||
ARWR | ARROWHEAD PHARMACEUTICALS INC | $2.57B | $545.21M | -$57.42M | -$143.97M | -$1.36 | 1,436.97% | 31.44% | N/A | N/A | 2025-08-11 | ||
XLO | XILIO THERAPEUTICS INC | $38.32M | $9.27M | -$52.61M | -$54.30M | -$0.82 | N/A | N/A | N/A | N/A | 2025-08-06 | ||
HRTX | HERON THERAPEUTICS INC | $323.43M | $148.52M | -$2.95M | -$7.79M | -$0.05 | 12.43% | 1.22% | N/A | N/A | 2025-08-12 | ||
MDXG | MIMEDX GROUP INC | $1.00B | $352.38M | $63.32M | $40.18M | $0.27 | 5.34% | 3.66% | -48.08% | N/A | 2025-07-29 | ||
IMAB | I-MAB | $174.71M | $0.00 | N/A | -$7.58M | -$0.12 | -100.00% | N/A | N/A | N/A | 2025-09-02 | ||
ONC | BEONE MEDICINES LTD | $27.24B | $4.18B | -$126.93M | -$392.37M | -$0.29 | 51.16% | 59.66% | N/A | N/A | |||
XOMA | XOMA ROYALTY CORP | $332.20M | $42.91M | $3.33M | -$5.60M | -$1.10 | 638.41% | 31.19% | N/A | N/A | 2025-08-06 | ||
ZYME | ZYMEWORKS INC | $930.27M | $93.38M | -$94.99M | -$113.68M | -$1.50 | 85.05% | 29.25% | N/A | N/A | |||
KROS | KEROS THERAPEUTICS INC | $591.77M | $214.71M | $17.92M | $4.21M | -$0.12 | 91,657.69% | 95.60% | N/A | N/A | 2025-07-31 | ||
TBPH | THERAVANCE BIOPHARMA INC | $573.52M | $65.27M | -$39.82M | -$58.33M | -$1.18 | 6.11% | -5.79% | N/A | N/A | 2025-08-04 | ||
RPRX | ROYALTY PHARMA PLC | $20.38B | $2.26B | $1.34B | $1.09B | $2.47 | 1.13% | 3.78% | 37.99% | N/A | 2025-08-06 | ||
ZLAB | ZAI LAB LTD | $3.72B | $418.33M | -$227.62M | -$252.07M | -$2.40 | 43.72% | N/A | N/A | N/A | 2025-08-11 | ||
STOK | STOKE THERAPEUTICS INC | $658.44M | $190.91M | $42.86M | $50.27M | $0.85 | 2,333.50% | N/A | N/A | N/A | 2025-08-11 | ||
GMAB | GENMAB A | $14.21B | $3.15B | N/A | $1.11B | $1.73 | 25.31% | 31.74% | 46.37% | 27.07% | 2025-08-07 | ||
ARGX | ARGENX SE | $34.10B | $4.73M | $114.32M | $905.48M | $15.13 | -88.53% | -44.77% | N/A | N/A | 2025-07-15 | ||
ATRA | ATARA BIOTHERAPEUTICS INC | $55.44M | $199.73M | $7.38M | -$15.64M | -$2.57 | 475.53% | N/A | N/A | N/A | |||
MNKD | MANNKIND CORP | $1.22B | $297.60M | $82.59M | $30.12M | $0.10 | 32.50% | 36.93% | 150.00% | N/A | 2025-08-06 | ||
VCYT | VERACYTE INC | $2.09B | $463.39M | $63.03M | $33.05M | $0.43 | 23.42% | 30.60% | N/A | N/A | 2025-07-30 | ||
XERS | XERIS BIOPHARMA HOLDINGS INC | $871.24M | $222.55M | -$4.34M | -$45.08M | -$0.30 | 29.88% | 120.58% | N/A | N/A | 2025-08-06 | ||
VRTX | VERTEX PHARMACEUTICALS INC | $121.30B | $11.10B | -$74.90M | -$988.90M | -$3.82 | 8.98% | 18.16% | N/A | N/A | 2025-07-30 | ||
ARQT | ARCUTIS BIOTHERAPEUTICS INC | $1.90B | $212.82M | -$100.65M | -$129.72M | -$1.03 | 100.03% | N/A | N/A | N/A | 2025-08-13 | ||
UTHR | UNITED THERAPEUTICS CORP | $13.43B | $2.99B | $1.68B | $1.21B | $27.08 | 19.85% | 15.73% | 21.11% | 17.60% | 2025-07-29 | ||
TECH | BIO-TECHNE CORP | $8.25B | $1.21B | $289.57M | $131.67M | $0.83 | 4.72% | 9.88% | -34.65% | -7.46% | 2025-08-12 | ||
TGTX | TG THERAPEUTICS INC | $6.18B | $386.39M | $70.41M | $39.15M | $0.27 | 33.54% | 379.77% | -6.90% | N/A | 2025-08-05 | ||
ACAD | ACADIA PHARMACEUTICALS INC | $3.66B | $996.28M | $278.16M | $228.88M | $1.38 | 22.42% | 22.16% | N/A | N/A | 2025-07-30 | ||
ADPT | ADAPTIVE BIOTECHNOLOGIES CORP | $1.75B | $189.53M | -$106.35M | -$141.84M | -$0.95 | 8.61% | 15.22% | N/A | N/A | 2025-07-30 | ||
MDGL | MADRIGAL PHARMACEUTICALS INC | $7.10B | $317.38M | -$376.50M | -$391.59M | -$17.93 | N/A | N/A | N/A | N/A | 2025-08-06 | ||
WHWK | WHITEHAWK THERAPEUTICS INC | $96.57M | $27.78M | $28.33M | $27.61M | $0.16 | 16.51% | N/A | N/A | N/A | |||
CORT | CORCEPT THERAPEUTICS INC | $7.72B | $685.45M | $110.98M | $132.49M | $1.27 | 30.93% | 15.40% | 10.43% | 6.66% | 2025-07-28 | ||
LGND | LIGAND PHARMACEUTICALS INC | $2.45B | $181.49M | -$119.89M | -$132.62M | -$7.20 | 53.40% | 10.54% | N/A | N/A | 2025-08-11 | ||
CTMX | CYTOMX THERAPEUTICS INC | $192.68M | $147.56M | $47.70M | $41.60M | $0.49 | 23.81% | 25.71% | 145.00% | N/A | 2025-08-07 | ||
NVAX | NOVAVAX INC | $1.13B | $1.25B | $554.90M | $478.70M | $3.03 | 25.92% | 133.56% | N/A | N/A | 2025-08-06 | ||
MIRM | MIRUM PHARMACEUTICALS INC | $2.64B | $379.25M | -$35.81M | -$77.34M | -$1.61 | 69.31% | N/A | N/A | N/A | 2025-07-31 | ||
CADL | CANDEL THERAPEUTICS INC | $322.16M | $0.00 | -$36.56M | -$39.58M | -$1.31 | N/A | N/A | N/A | N/A | 2025-09-03 | ||
AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | $3.15B | $134.15M | -$32.47M | -$55.46M | -$0.73 | 329.06% | N/A | N/A | N/A | 2025-07-17 | ||
SPRO | SPERO THERAPEUTICS INC | $147.60M | $44.58M | -$69.76M | -$69.76M | -$1.28 | -59.83% | 29.74% | N/A | N/A | 2025-08-07 | ||
SEER | SEER INC | $125.39M | $15.31M | -$79.33M | -$85.87M | -$1.41 | -2.33% | N/A | N/A | N/A | 2025-08-07 | ||
IPSC | CENTURY THERAPEUTICS INC | $51.70M | $114.90M | -$8.40M | -$21.95M | -$0.29 | 8,286.79% | N/A | N/A | N/A | 2025-08-07 | ||
RGNX | REGENXBIO INC | $436.40M | $156.72M | -$122.44M | -$157.69M | -$3.10 | 80.70% | 24.69% | N/A | N/A | 2025-07-30 | ||
ACOG | ALPHA COGNITION INC | $168.69M | $2.93M | -$11.47M | -$11.64M | -$1.30 | N/A | N/A | N/A | N/A | |||
SEPN | SEPTERNA INC | $535.15M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2025-09-03 | ||
FHTX | FOGHORN THERAPEUTICS INC | $327.76M | $23.50M | -$71.61M | -$80.44M | -$1.36 | -30.66% | N/A | N/A | N/A | 2025-08-12 | ||
MESO | MESOBLAST LTD | $1.29B | $5.67M | N/A | -$103.35M | -$0.93 | -24.07% | -24.07% | N/A | N/A | 2025-08-27 | ||
TVTX | TRAVERE THERAPEUTICS INC | $1.50B | $273.53M | -$169.03M | -$226.71M | -$2.79 | 75.65% | 8.31% | N/A | N/A | 2025-07-30 | ||
MCRB | SERES THERAPEUTICS INC | $129.68M | $0.00 | $90.27M | $72.95M | $8.76 | -100.00% | -100.00% | N/A | N/A | 2025-08-05 | ||
GLUE | MONTE ROSA THERAPEUTICS INC | $323.54M | $159.49M | $17.73M | $6.15M | $0.08 | 14,889.38% | N/A | N/A | N/A | 2025-08-07 | ||
TSHA | TAYSHA GENE THERAPIES INC | $566.71M | $7.22M | -$84.24M | -$86.77M | -$0.34 | -48.97% | N/A | N/A | N/A | 2025-08-18 | ||
TARS | TARSUS PHARMACEUTICALS INC | $1.74B | $233.67M | -$93.78M | -$104.94M | -$2.72 | 449.03% | N/A | N/A | N/A | 2025-08-07 | ||
ACIU | AC IMMUNE SA | $208.85M | $34.51M | -$60.62M | -$63.52M | -$0.63 | 91.20% | -8.33% | N/A | N/A | 2025-08-06 | ||
AGEN | AGENUS INC | $187.26M | $99.52M | -$76.47M | -$190.81M | -$8.57 | -38.34% | 3.14% | N/A | N/A | |||
ASND | ASCENDIS PHARMA A | $10.61B | $418.98M | -$194.68M | -$388.26M | -$6.65 | 12.06% | 104.09% | N/A | N/A | 2025-09-09 | ||
KYMR | KYMERA THERAPEUTICS INC | $2.92B | $58.89M | -$232.67M | -$240.88M | -$3.11 | -25.85% | N/A | N/A | N/A | 2025-08-01 | ||
FOLD | AMICUS THERAPEUTICS INC | $1.92B | $543.14M | $53.63M | -$29.37M | -$0.09 | 28.25% | 21.08% | N/A | N/A | 2025-07-31 | ||
NTRB | NUTRIBAND INC | $89.68M | $2.40M | -$9.65M | -$9.97M | -$0.90 | 18.92% | 51.92% | N/A | N/A | |||
FTRE | FORTREA HOLDINGS INC | $450.90M | $2.69B | -$577.60M | -$790.40M | -$8.79 | -4.45% | N/A | N/A | N/A | 2025-08-18 | ||
GYRE | GYRE THERAPEUTICS INC | $713.50M | $100.64M | $13.36M | $7.25M | $0.08 | -13.01% | 43.80% | N/A | N/A | 2025-08-19 | ||
KRYS | KRYSTAL BIOTECH INC | $4.35B | $333.45M | $144.76M | $123.96M | $4.32 | 247.53% | N/A | 118.18% | N/A | 2025-08-11 | ||
ATAI | ATAI LIFE SCIENCES NV | $544.92M | $1.86M | -$144.77M | -$148.99M | -$0.91 | 572.56% | N/A | N/A | N/A | 2025-08-18 | ||
TLX | TELIX PHARMACEUTICALS LTD | $5.21B | $492.58M | $58.49M | $31.40M | N/A | 42.30% | N/A | N/A | N/A | 2025-08-20 | ||
FULC | FULCRUM THERAPEUTICS INC | $426.44M | $80.00M | $957.00k | -$510.00k | -$0.01 | 3,087.25% | 154.45% | N/A | N/A | 2025-08-06 | ||
HLVX | HILLEVAX INC | $108.81M | $0.00 | -$100.93M | -$106.50M | -$2.16 | N/A | N/A | N/A | N/A | 2025-08-07 | ||
AEON | AEON BIOPHARMA INC | $9.44M | $0.00 | $169.21M | $169.12M | $297.46 | N/A | N/A | N/A | N/A | |||
VRCA | VERRICA PHARMACEUTICALS INC | $75.38M | $7.18M | -$55.56M | -$65.99M | -$1.14 | -19.45% | N/A | N/A | N/A | 2025-08-12 | ||
ANIX | ANIXA BIOSCIENCES INC | $103.08M | $0.00 | -$12.10M | -$12.13M | -$0.38 | N/A | N/A | N/A | N/A | 2025-09-12 | ||
LEGN | LEGEND BIOTECH CORP | $7.26B | $728.30M | -$153.44M | -$218.15M | -$1.20 | 112.46% | 63.96% | N/A | N/A | 2025-08-29 | ||
ARVN | ARVINAS INC | $574.44M | $426.90M | -$39.80M | -$46.60M | -$0.66 | 498.74% | 56.67% | N/A | N/A | 2025-07-28 | ||
CNTA | CENTESSA PHARMACEUTICALS PLC | $2.02B | $15.00M | -$208.73M | -$223.85M | -$1.88 | 118.88% | N/A | N/A | N/A | 2025-08-18 | ||
ERAS | ERASCA INC | $413.60M | $0.00 | -$153.97M | -$157.60M | -$0.60 | N/A | N/A | N/A | N/A | 2025-08-07 | ||
ASMB | ASSEMBLY BIOSCIENCES INC | $143.89M | $0.00 | -$39.46M | -$39.92M | -$6.23 | N/A | -100.00% | N/A | N/A | |||
LCTX | LINEAGE CELL THERAPEUTICS INC | $244.34M | $9.56M | -$15.61M | -$16.21M | -$0.08 | 19.42% | 25.25% | N/A | N/A | 2025-08-07 | ||
SLS | SELLAS LIFE SCIENCES GROUP INC | $197.56M | $0.00 | -$26.56M | -$27.13M | -$0.38 | N/A | N/A | N/A | N/A | 2025-08-07 | ||
MBIO | MUSTANG BIO INC | $10.59M | $0.00 | -$10.54M | -$10.71M | -$27.12 | N/A | N/A | N/A | N/A | |||
CDTX | CIDARA THERAPEUTICS INC | $717.49M | $302.00k | -$181.59M | -$182.98M | -$26.09 | -98.33% | -58.12% | N/A | N/A | |||
ABVC | ABVC BIOPHARMA INC | $58.87M | $508.38k | -$1.24M | -$1.81M | -$0.13 | 1,904.43% | N/A | N/A | N/A | |||
ADCT | ADC THERAPEUTICS SA | $332.25M | $75.82M | -$96.50M | -$149.84M | -$1.43 | 10.49% | 107.69% | N/A | N/A | 2025-08-12 | ||
TVRD | TVARDI THERAPEUTICS INC | $279.24M | $7.57M | -$35.47M | -$45.08M | -$30.01 | -55.30% | -20.34% | N/A | N/A | 2025-08-12 |